The Food and Drug Administration announced on Feb. 7, 2019, that ACP Nimble Buyer, Inc. voluntarily recalled Mometasone Furoate Cream due to a labeling error involving an NDC typographical mistake. The agency issued recall number D-0514-2019 for the Class III drug.
How to tell if you have it
- Brand: ACP Nimble Buyer
- Product: Mometasone Furoate Cream, 0.1%, 45 g tube
- NDC: 0713-0726-37
- Lot codes: 1009431 (Exp. 08/2020), 1009507 (Exp. 08/2020), 1009886 (Exp. 09/2020)
- Manufacturer: G&W Laboratories, Inc.
- Units affected: 58,176
The hazard
The recall addresses a labeling hazard where Mometasone Furoate Cream contains an NDC typographical error. The FDA classified the issue as Class III, indicating it is not likely to cause adverse health consequences.
Context
GovInfoNow's records show other recent recalls of similar products include ACME Dynarex Antiseptic Towelettes (2026-01-20) and Leading Pharma Furosemide 80mg (2026-03-20). Additional recent actions involve Nivagen Zinc Oxide Ointment recalled on 2025-10-31 for CGMP deviations.